This Recent FDA Approval Is Bad News for Pfizer

This Recent FDA Approval Is Bad News for Pfizer

Source: 
Motley Fool
snippet: 
  • Pfizer dominates the pneumococcal vaccine market.
  • However, Merck has obtained approval for a pneumococcal vaccine
  • Merck's new medication could become the new top seller for this indication.